vs

Side-by-side financial comparison of PAMT CORP (PAMT) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.

Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $141.3M, roughly 1.5× PAMT CORP). Varex Imaging Corp runs the higher net margin — 1.1% vs -20.7%, a 21.8% gap on every dollar of revenue. On growth, Varex Imaging Corp posted the faster year-over-year revenue change (4.9% vs -15.1%). PAMT CORP produced more free cash flow last quarter ($-25.0M vs $-26.8M). Over the past eight quarters, Varex Imaging Corp's revenue compounded faster (0.8% CAGR vs -12.0%).

Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.

PAMT vs VREX — Head-to-Head

Bigger by revenue
VREX
VREX
1.5× larger
VREX
$209.6M
$141.3M
PAMT
Growing faster (revenue YoY)
VREX
VREX
+20.0% gap
VREX
4.9%
-15.1%
PAMT
Higher net margin
VREX
VREX
21.8% more per $
VREX
1.1%
-20.7%
PAMT
More free cash flow
PAMT
PAMT
$1.8M more FCF
PAMT
$-25.0M
$-26.8M
VREX
Faster 2-yr revenue CAGR
VREX
VREX
Annualised
VREX
0.8%
-12.0%
PAMT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PAMT
PAMT
VREX
VREX
Revenue
$141.3M
$209.6M
Net Profit
$-29.3M
$2.3M
Gross Margin
33.3%
Operating Margin
-27.0%
7.3%
Net Margin
-20.7%
1.1%
Revenue YoY
-15.1%
4.9%
Net Profit YoY
7.4%
866.7%
EPS (diluted)
$-1.38
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PAMT
PAMT
VREX
VREX
Q1 26
$209.6M
Q4 25
$141.3M
$228.9M
Q3 25
$150.3M
$203.0M
Q2 25
$151.1M
$212.9M
Q1 25
$155.3M
$199.8M
Q4 24
$166.5M
Q3 24
$182.6M
$205.7M
Q2 24
$182.9M
$209.1M
Net Profit
PAMT
PAMT
VREX
VREX
Q1 26
$2.3M
Q4 25
$-29.3M
$12.2M
Q3 25
$-5.6M
$-89.1M
Q2 25
$-9.6M
$6.9M
Q1 25
$-8.1M
$-300.0K
Q4 24
$-31.6M
Q3 24
$2.4M
$-51.1M
Q2 24
$-2.9M
$1.4M
Gross Margin
PAMT
PAMT
VREX
VREX
Q1 26
33.3%
Q4 25
34.0%
Q3 25
33.3%
Q2 25
36.0%
Q1 25
34.3%
Q4 24
Q3 24
32.6%
Q2 24
32.0%
Operating Margin
PAMT
PAMT
VREX
VREX
Q1 26
7.3%
Q4 25
-27.0%
8.6%
Q3 25
-3.8%
-39.8%
Q2 25
-7.3%
10.4%
Q1 25
-5.9%
5.6%
Q4 24
-22.6%
Q3 24
1.3%
5.3%
Q2 24
-0.4%
4.4%
Net Margin
PAMT
PAMT
VREX
VREX
Q1 26
1.1%
Q4 25
-20.7%
5.3%
Q3 25
-3.7%
-43.9%
Q2 25
-6.4%
3.2%
Q1 25
-5.2%
-0.2%
Q4 24
-19.0%
Q3 24
1.3%
-24.8%
Q2 24
-1.6%
0.7%
EPS (diluted)
PAMT
PAMT
VREX
VREX
Q1 26
$0.05
Q4 25
$-1.38
$0.29
Q3 25
$-0.27
$-2.15
Q2 25
$-0.46
$0.17
Q1 25
$-0.37
$-0.01
Q4 24
$-1.44
Q3 24
$0.11
$-1.25
Q2 24
$-0.13
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PAMT
PAMT
VREX
VREX
Cash + ST InvestmentsLiquidity on hand
$83.7M
$125.6M
Total DebtLower is stronger
$333.9M
$367.6M
Stockholders' EquityBook value
$210.5M
$476.9M
Total Assets
$697.9M
$1.1B
Debt / EquityLower = less leverage
1.59×
0.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PAMT
PAMT
VREX
VREX
Q1 26
$125.6M
Q4 25
$83.7M
$155.1M
Q3 25
$115.6M
$152.6M
Q2 25
$117.3M
$223.0M
Q1 25
$102.7M
$212.6M
Q4 24
$110.7M
Q3 24
$92.3M
$200.5M
Q2 24
$114.0M
$190.0M
Total Debt
PAMT
PAMT
VREX
VREX
Q1 26
$367.6M
Q4 25
$333.9M
$367.5M
Q3 25
$367.5M
Q2 25
$567.2M
Q1 25
$567.0M
Q4 24
$325.6M
Q3 24
$443.4M
Q2 24
$443.1M
Stockholders' Equity
PAMT
PAMT
VREX
VREX
Q1 26
$476.9M
Q4 25
$210.5M
$472.6M
Q3 25
$239.5M
$455.3M
Q2 25
$244.9M
$549.7M
Q1 25
$269.6M
$540.2M
Q4 24
$277.5M
Q3 24
$308.9M
$529.1M
Q2 24
$306.7M
$581.2M
Total Assets
PAMT
PAMT
VREX
VREX
Q1 26
$1.1B
Q4 25
$697.9M
$1.1B
Q3 25
$715.2M
$1.1B
Q2 25
$707.9M
$1.4B
Q1 25
$712.6M
$1.3B
Q4 24
$741.7M
Q3 24
$756.7M
$1.2B
Q2 24
$733.5M
$1.3B
Debt / Equity
PAMT
PAMT
VREX
VREX
Q1 26
0.77×
Q4 25
1.59×
0.78×
Q3 25
0.81×
Q2 25
1.03×
Q1 25
1.05×
Q4 24
1.17×
Q3 24
0.84×
Q2 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PAMT
PAMT
VREX
VREX
Operating Cash FlowLast quarter
$-5.8M
$-16.1M
Free Cash FlowOCF − Capex
$-25.0M
$-26.8M
FCF MarginFCF / Revenue
-17.7%
-12.8%
Capex IntensityCapex / Revenue
13.6%
5.1%
Cash ConversionOCF / Net Profit
-7.00×
TTM Free Cash FlowTrailing 4 quarters
$-23.4M
$-13.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PAMT
PAMT
VREX
VREX
Q1 26
$-16.1M
Q4 25
$-5.8M
$7.9M
Q3 25
$5.9M
$7.7M
Q2 25
$12.2M
$16.6M
Q1 25
$5.0M
$9.5M
Q4 24
$15.2M
Q3 24
$15.5M
$25.9M
Q2 24
$18.7M
$8.0M
Free Cash Flow
PAMT
PAMT
VREX
VREX
Q1 26
$-26.8M
Q4 25
$-25.0M
$2.3M
Q3 25
$2.5M
$1.4M
Q2 25
$5.9M
$9.8M
Q1 25
$-6.8M
$5.3M
Q4 24
$-39.9M
Q3 24
$-33.6M
$19.9M
Q2 24
$4.1M
$3.3M
FCF Margin
PAMT
PAMT
VREX
VREX
Q1 26
-12.8%
Q4 25
-17.7%
1.0%
Q3 25
1.7%
0.7%
Q2 25
3.9%
4.6%
Q1 25
-4.4%
2.7%
Q4 24
-24.0%
Q3 24
-18.4%
9.7%
Q2 24
2.2%
1.6%
Capex Intensity
PAMT
PAMT
VREX
VREX
Q1 26
5.1%
Q4 25
13.6%
2.4%
Q3 25
2.3%
3.1%
Q2 25
4.2%
3.2%
Q1 25
7.6%
2.1%
Q4 24
33.1%
Q3 24
26.9%
2.9%
Q2 24
8.0%
2.2%
Cash Conversion
PAMT
PAMT
VREX
VREX
Q1 26
-7.00×
Q4 25
0.65×
Q3 25
Q2 25
2.41×
Q1 25
Q4 24
Q3 24
6.44×
Q2 24
5.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PAMT
PAMT

Freight Transportation Service$123.1M87%
Fuel Surcharge$18.2M13%

VREX
VREX

Medical Segment$144.8M69%
Industrial Segment$64.8M31%

Related Comparisons